Recent benchmarks report that deep-learning-based genetic perturbation models fail to outperform uninformative baselines. Here we introduce a positive control baseline and metric calibration framework, showing—across 14 datasets and 18 metrics—that common benchmarking metrics (for example, mean squared error and Pearson Δ ) are frequently miscalibrated, with reduced sensitivity to measure positive model performance. Under well-calibrated metrics, we find that deep-learning-based genetic perturbation models can outperform uninformative baselines.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: